New ‘mutation-tracking’ blood test could predict breast cancer relapse months in advance - The Institute of Cancer Research, London

New ‘mutation-tracking’ blood test could predict breast cancer relapse months in advance - The Institute of Cancer Research, London

New ‘mutation-tracking’ blood test could predict breast cancer relapse months in advance

Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans

The test can uncover small numbers of residual cancer cells that have resisted therapy by detecting cancer DNA in the bloodstream.